Wells Fargo & Company PREVAIL THERAPEUTICS INC Call Options Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

Call Options

2 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q1 2021

May 13, 2021
SELL
N/A
-51,200 Closed
0 $0
Q4 2020

Feb 09, 2021
BUY
N/A
51,200 New
51,200 $6,000
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email